Notably, the increase in levels of these p-tau forms seems specific to AD and does not occur in other tauopathies such as corticobasal degeneration (CBD), progressive supranuclear palsy (PSP), or frontotemporal lobar degeneration (FTLD)68,75. This evidence concerns the gene MAPT and Alzheimer disease.